Company / Capital Expenditures
PTC Therapeutics, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$8.9M
FY2025
5-year range
$6.5M / $28.4M
FY2021-FY2025
Trend
+36.3%
vs FY2024
Sector context
#62 of 194
Health Care
What the data says
At $9M, PTC Therapeutics, Inc.'s capital expenditures ranks #62 of 194 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $2M in FY2016 to $28M in FY2023.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +4.5%.
Declined from $28M to $9M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -20.8%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
#62 of 194 in Health CareTop 32% of 194This company $8.9M Sector average $117.5M
▼
-92.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.5%, indicating consistent growth.
- In FY2025, capital expenditures increased 36.3% year-over-year.
- Ranks #62 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.9M | +36.3% |
| FY2024 | $6.5M | -77.1% |
| FY2023 | $28.4M | +59.4% |
| FY2022 | $17.8M | +29.7% |
| FY2021 | $13.8M | +93.8% |
| FY2020 | $7.1M | -48.4% |
| FY2019 | $13.8M | +93.8% |
| FY2018 | $7.1M | +128.9% |
| FY2017 | $3.1M | +74.6% |
| FY2016 | $1.8M | -34.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026